{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:38:34Z","timestamp":1778852314385,"version":"3.51.4"},"reference-count":46,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Medicine and Pharmacy \u201cCarol Davila\u201d"}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Dyspnea accompanies end-of-life in many cancer patients, with around 50% experiencing moderate\/severe dyspnea, and is an independent factor for poor prognosis and declining quality of life. Managing dyspnea becomes a key component of palliative treatment and end-of-life support for cancer patients. Opioids seem to be the obvious choice in cancer patients as they also address the pain component (often important in such patients). Evidence-based conclusions on the effectiveness\/safety of opioids in dyspnea management are scarce, and the results are still controversial. We aim to address this knowledge gap. Methods: In order to achieve the objective of this paper, we conducted a comprehensive search of international databases (PubMed, Medline, Embase, and Cochrane Library) for randomized controlled trials on the use of opioids to treat refractory dyspnea in adult cancer patients, and we performed a pooled meta-analysis of the results. Results: The effect of opioids on the relief of dyspnea was significant (SMD \u22120.44, 95% CI [\u22120.75,\u22120.12], p = 0.007). The significance of the opioid effect is maintained only for morphine administration (SMD \u2212078, 95% CI [\u22121.45,\u22120.10], p = 0.02) and only for exertional dyspnea (SMD \u22121.00, 95% CI [\u22121.98, \u22120.03], p = 0.04). No correlation was noted between fentanyl\/hydromorphone and dyspnea relief or opioids administered for dyspnea at rest. The subcutaneous route seems to be significantly correlated with dyspnea relief (SMD \u22120.73, 95% CI [\u22121.27, \u22120.19], p = 0.008), while the other administration modalities lack such an effect. No significant correlation was present between the usage of morphine\/fentanyl and increased odds of severe adverse effects (OR 1.48, 95% CI [0.57,3.86], p = 0.42); however, fentanyl seems to be associated with increased somnolence. Although we aimed to evaluate how opioids impact the quality of life of cancer patients with dyspnea, we were unable to obtain such results due to the absolute lack of the literature available discussing QoL. Conclusions: Although we managed to provide some insights into the efficiency and safety of opioids usage for dyspnea management in cancer patients, the evidence based on the available literature is low grade. There is a marked need to address this knowledge gap with future high-quality studies with large sample sizes and standardized protocols.<\/jats:p>","DOI":"10.3390\/cancers17081368","type":"journal-article","created":{"date-parts":[[2025,4,20]],"date-time":"2025-04-20T20:15:06Z","timestamp":1745180106000},"page":"1368","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Systematic Review and Meta-Analysis on Opioid Management of Dyspnea in Cancer Patients"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9225-8030","authenticated-orcid":false,"given":"Elena","family":"Chitoran","sequence":"first","affiliation":[{"name":"Medicine School, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"General Surgery and Surgical Oncology Department I, Bucharest Institute of Oncology \u201cProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6161-1951","authenticated-orcid":false,"given":"Vlad","family":"Rotaru","sequence":"additional","affiliation":[{"name":"Medicine School, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"General Surgery and Surgical Oncology Department I, Bucharest Institute of Oncology \u201cProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4269-4269","authenticated-orcid":false,"given":"Giuseppe","family":"Gullo","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Villa Sofia Cervello Hospital, University of Palermo, 90146 Palermo, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela Viorica","family":"Mosoiu","sequence":"additional","affiliation":[{"name":"Medicine School, \u201cTransilvania\u201d University, 500036 Brasov, Romania"},{"name":"Hospice \u201cCasa Sperantei\u201d, 500074 Brasov, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurentiu","family":"Simion","sequence":"additional","affiliation":[{"name":"Medicine School, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"General Surgery and Surgical Oncology Department I, Bucharest Institute of Oncology \u201cProf. Dr. Alexandru Trestioreanu\u201d, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S1478951503030499","article-title":"Breathlessness in Cancer and Chronic Obstructive Pulmonary Disease: Using a Qualitative Approach to Describe the Experience of Patients and Carers","volume":"1","author":"Booth","year":"2003","journal-title":"Palliat. Support. Care"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Chan, K.-S., Tse, D.M.W., and Sham, M.M.K. (2015). Dyspnoea and Other Respiratory Symptoms in Palliative Care. Oxford Textbook of Palliative Medicine, Oxford Academic.","DOI":"10.1093\/med\/9780199656097.003.0082"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/1049909108327588","article-title":"Dyspnea\u2014a Bad Prognosis Symptom at the End of Life","volume":"26","author":"Vargas","year":"2009","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jpainsymman.2009.09.017","article-title":"Do the Trajectories of Dyspnea Differ in Prevalence and Intensity by Diagnosis at the End of Life? A Consecutive Cohort Study","volume":"39","author":"Currow","year":"2010","journal-title":"J. Pain Symptom Manag."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/S0885-3924(00)00160-3","article-title":"The Course of Symptom Frequency and Intensity in Advanced Cancer Patients Followed at Home","volume":"20","author":"Mercadante","year":"2000","journal-title":"J. Pain Symptom Manag."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e001038","DOI":"10.1136\/esmoopen-2020-001038","article-title":"Management of Breathlessness in Patients with Cancer: ESMO Clinical Practice Guidelines","volume":"5","author":"Hui","year":"2020","journal-title":"ESMO Open"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1089\/jpm.2016.0145","article-title":"Treatment Recommendations for Respiratory Symptoms in Cancer Patients: Clinical Guidelines from the Japanese Society for Palliative Medicine","volume":"19","author":"Yamaguchi","year":"2016","journal-title":"J. Palliat. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.20.03465","article-title":"Management of Dyspnea in Advanced Cancer: ASCO Guideline","volume":"39","author":"Hui","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/thoraxjnl-2016-209868","article-title":"One Evidence Base; Three Stories: Do Opioids Relieve Chronic Breathlessness?","volume":"73","author":"Bajwah","year":"2018","journal-title":"Thorax"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jpainsymman.2011.04.024","article-title":"Gaps in the Evidence Base of Opioids for Refractory Breathlessness. A Future Work Plan?","volume":"43","author":"Johnson","year":"2012","journal-title":"J. Pain Symptom Manag."},{"key":"ref_11","first-page":"CD011008","article-title":"Opioids for the Palliation of Refractory Breathlessness in Adults with Advanced Disease and Terminal Illness","volume":"2016","author":"Barnes","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jpainsymman.2013.02.019","article-title":"Fentanyl for the Relief of Refractory Breathlessness: A Systematic Review","volume":"46","author":"Simon","year":"2013","journal-title":"J. Pain Symptom Manag."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3109\/0284186X.2012.709638","article-title":"Interventions for Alleviating Cancer-Related Dyspnea: A Systematic Review and Meta-Analysis","volume":"51","author":"Leibovici","year":"2012","journal-title":"Acta Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_15","unstructured":"(2024, March 06). National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) Common Terminology Criteria for Adverse Events (CTCAE) v5.0, Available online: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/ctcae_v5_quick_reference_5x7.pdf."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1136\/emermed-2020-209567","article-title":"Population, Intervention, Comparison, Outcomes and Study (PICOS) Design as a Framework to Formulate Eligibility Criteria in Systematic Reviews","volume":"37","author":"Janati","year":"2020","journal-title":"Emerg. Med. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s Tool for Assessing Risk of Bias in Randomised Trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"ref_18","unstructured":"(2023, January 24). RevMan|Cochrane Training. Available online: https:\/\/training.cochrane.org\/online-learning\/core-software\/revman."},{"key":"ref_19","unstructured":"(2023, January 28). Mendeley Reference Manager|Mendeley. Available online: https:\/\/www.mendeley.com\/reference-management\/reference-manager."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"00167-2023","DOI":"10.1183\/23120541.00167-2023","article-title":"Modified-Release Morphine or Placebo for Chronic Breathlessness: The MABEL Trial Protocol","volume":"9","author":"Date","year":"2023","journal-title":"ERJ Open Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejca.2016.03.078","article-title":"A Randomised Study Comparing the Effectiveness of Acupuncture or Morphine versus the Combination for the Relief of Dyspnoea in Patients with Advanced Non-Small Cell Lung Cancer and Mesothelioma","volume":"61","author":"Minchom","year":"2016","journal-title":"Eur. J. Cancer"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0761-8425(04)71583-1","article-title":"Dyspn\u00e9e et A\u00e9rosols de Morphine Dans Les Soins Palliatifs Du Cancer Broncho-Pulmonaire","volume":"21","author":"Grimbert","year":"2004","journal-title":"Rev. Des Mal. Respir."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jpainsymman.2016.05.013","article-title":"Impact of Prophylactic Fentanyl Pectin Nasal Spray on Exercise-Induced Episodic Dyspnea in Cancer Patients: A Double-Blind, Randomized Controlled Trial","volume":"52","author":"Hui","year":"2016","journal-title":"J. Pain Symptom Manag."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jpainsymman.2013.03.017","article-title":"Effects of Prophylactic Subcutaneous Fentanyl on Exercise-Induced Breakthrough Dyspnea in Cancer Patients: A Preliminary Double-Blind, Randomized, Controlled Trial","volume":"47","author":"Hui","year":"2014","journal-title":"J. Pain Symptom Manag."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jpainsymman.2017.08.001","article-title":"Effect of Prophylactic Fentanyl Buccal Tablet on Episodic Exertional Dyspnea: A Pilot Double-Blind Randomized Controlled Trial","volume":"54","author":"Hui","year":"2017","journal-title":"J. Pain Symptom Manag."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpainsymman.2016.05.023","article-title":"EffenDys-Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Patients With Advanced Cancer: A Multicenter, Open-Label, Randomized, Morphine-Controlled, Crossover, Phase II Trial","volume":"52","author":"Simon","year":"2016","journal-title":"J. Pain Symptom Manag."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jjco\/hyy139","article-title":"Efficacy of Immediate-Release Oxycodone for Dyspnoea in Cancer Patient: Cancer Dyspnoea Relief (CDR) Trial","volume":"48","author":"Yamaguchi","year":"2018","journal-title":"Jpn. J. Clin. Oncol."},{"key":"ref_28","first-page":"64","article-title":"Single Dose Randomised Controlled Trial of Nebulised Morphine in Patients with Cancer Related Breathlessness","volume":"10","author":"Davis","year":"1996","journal-title":"Palliat. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpainsymman.2005.06.009","article-title":"Midazolam as Adjunct Therapy to Morphine in the Alleviation of Severe Dyspnea Perception in Patients with Advanced Cancer","volume":"31","author":"Navigante","year":"2006","journal-title":"J. Pain Symptom Manag."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7326\/0003-4819-119-9-199311010-00007","article-title":"Subcutaneous Morphine for Dyspnea in Cancer Patients","volume":"119","author":"Bruera","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jpainsymman.2004.08.016","article-title":"Nebulized versus Subcutaneous Morphine for Patients with Cancer Dyspnea: A Preliminary Study","volume":"29","author":"Bruera","year":"2005","journal-title":"J. Pain Symptom Manag."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jpainsymman.2007.08.016","article-title":"Relief of Incident Dyspnea in Palliative Cancer Patients: A Pilot, Randomized, Controlled Trial Comparing Nebulized Hydromorphone, Systemic Hydromorphone, and Nebulized Saline","volume":"36","author":"Charles","year":"2008","journal-title":"J. Pain Symptom Manag."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1023\/A:1008337624200","article-title":"The Effects of Morphine on Dyspnea and Ventilatory Function in Elderly Patients with Advanced Cancer: A Randomized Double-Blind Controlled Trial","volume":"10","author":"Mazzocato","year":"1999","journal-title":"Ann. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.jpainsymman.2009.10.003","article-title":"Morphine versus Midazolam as Upfront Therapy to Control Dyspnea Perception in Cancer Patients While Its Underlying Cause Is Sought or Treated","volume":"39","author":"Navigante","year":"2010","journal-title":"J. Pain Symptom Manag."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/1049909113513063","article-title":"A Randomized Crossover Clinical Trial to Evaluate the Efficacy of Oral Transmucosal Fentanyl Citrate in the Treatment of Dyspnea on Exertion in Patients with Advanced Cancer","volume":"32","author":"Pinna","year":"2015","journal-title":"Am. J. Hosp. Palliat. Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.jpainsymman.2021.05.001","article-title":"Visualizing How to Use Parenteral Opioids for Terminal Cancer Dyspnea: A Pilot, Multicenter, Prospective, Observational Study","volume":"62","author":"Mori","year":"2021","journal-title":"J. Pain Symptom Manag."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1300\/J251v05n01_11","article-title":"American Opiophobia","volume":"5","author":"Morgan","year":"1985","journal-title":"Adv. Alcohol Subst. Abus."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s10147-023-02362-6","article-title":"Opioids for the Management of Dyspnea in Cancer Patients: A Systematic Review and Meta-Analysis","volume":"28","author":"Takagi","year":"2023","journal-title":"Int. J. Clin. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1200\/JCO.2007.13.3439","article-title":"The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials","volume":"26","author":"Gotay","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jpainsymman.2020.07.021","article-title":"Efficacy and Safety of Opioids in Treating Cancer-Related Dyspnea: A Systematic Review and Meta-Analysis Based on Randomized Controlled Trials","volume":"61","author":"Luo","year":"2021","journal-title":"J. Pain Symptom Manag."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.jpainsymman.2014.05.005","article-title":"Ethical Conduct of Palliative Care Research: Enhancing Communication Between Investigators and Institutional Review Boards","volume":"48","author":"Abernethy","year":"2014","journal-title":"J. Pain Symptom Manag."},{"key":"ref_42","unstructured":"Addington-Hall, J.M., Bruera, E., Higginson, I.J., and Payne, S. (2011). Research Methods in Palliative Care, Oxford Academic."},{"key":"ref_43","unstructured":"Rotaru, V., Chitoran, E., Cirimbei, C., Cirimbei, S., and Simion, L. (2018, January 25\u201327). Preservation of Sensory Nerves During Axillary Lymphadenectomy. Proceedings of the 35th Balkan Medical Week, Athens, Greece. Available online: https:\/\/www.webofscience.com\/wos\/woscc\/full-record\/WOS:000471903700045."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Manea, E., Chitoran, E., Rotaru, V., Ionescu, S., Luca, D., Cirimbei, C., Alecu, M., Capsa, C., Gafton, B., and Prutianu, I. (2024). Integration of Ultrasound in Image-Guided Adaptive Brachytherapy in Cancer of the Uterine Cervix. Bioengineering, 11.","DOI":"10.3390\/bioengineering11050506"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Simion, L., Rotaru, V., Cirimbei, C., Stefan, D.-C., Gherghe, M., Ionescu, S., Tanase, B.C., Luca, D.C., Gales, L.N., and Chitoran, E. (2023). Analysis of Efficacy-To-Safety Ratio of Angiogenesis-Inhibitors Based Therapies in Ovarian Cancer: A Systematic Review and Meta-Analysis. Diagnostics, 13.","DOI":"10.20944\/preprints202302.0030.v1"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Chitoran, E., Rotaru, V., Mitroiu, M.-N., Durdu, C.-E., Bohiltea, R.-E., Ionescu, S.-O., Gelal, A., Cirimbei, C., Alecu, M., and Simion, L. (2024). Navigating Fertility Preservation Options in Gynecological Cancers: A Comprehensive Review. Cancers, 16.","DOI":"10.3390\/cancers16122214"}],"updated-by":[{"DOI":"10.3390\/cancers18091488","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000}}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/8\/1368\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T20:21:35Z","timestamp":1778530895000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/8\/1368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":46,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["cancers17081368"],"URL":"https:\/\/doi.org\/10.3390\/cancers17081368","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]}}}